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Insulin resistance is a major cause of diabetes and
is highly associated with adipose tissue (AT) inflam-
mation in obesity. RBP4, a retinol transporter, is
elevated in insulin resistance and contributes to
increased diabetes risk. We aimed to determine the
mechanisms for RBP4-induced insulin resistance.
Here we show that RBP4 elevation causes AT inflam-
mation by activating innate immunity that elicits an
adaptive immune response. RBP4-overexpressing
mice (RBP4-Ox) are insulin resistant and glucose
intolerant and have increased AT macrophage and
CD4 T cell infiltration. In RBP4-Ox, AT CD206+ mac-
rophages express proinflammatory markers and
activate CD4 T cells while maintaining alternatively
activated macrophage markers. These effects result
from direct activation of AT antigen-presenting cells
(APCs) by RBP4 through a JNK-dependent pathway.
Transfer of RBP4-activated APCs into normal mice
is sufficient to induce AT inflammation, insulin resis-
tance, and glucose intolerance. Thus, RBP4 causes
insulin resistance, at least partly, by activating AT
APCs that induce CD4 T cell Th1 polarization and
AT inflammation.
INTRODUCTION
The immune system plays an important role in obesity-related
insulin resistance, which is a major pathogenic factor in type 2
diabetes (T2D) and the related cardiovascular disease (Moraes-
Vieira et al., 2012; Olefsky and Glass, 2010; Weisberg et al.,
2003; Xu et al., 2002). Large epidemiologic studies demonstrate
that elevated circulating RBP4 levels are a biomarker for insulin
resistance, prediabetes, the metabolic syndrome (Meisinger
et al., 2011; Qi et al., 2007), and myocardial infarction (Sun
et al., 2013). Genetic studies indicate that elevated RBP4 mark-
edly increases diabetes risk and may play a causative role in
the disease (van Hoek et al., 2008). Emerging evidence suggests
a possible role for proinflammatory pathways in RBP4-induced
insulin resistance. RBP4 levels in serum (Balagopal et al., 2007)
and AT (Yao-Borengasser et al., 2007) strongly correlate with512 Cell Metabolism 19, 512–526, March 4, 2014 ª2014 Elsevier Inc.subclinical inflammation, including proinflammatory cytokine
levels. RBP4 impairs insulin signaling in adipocytes indirectly
by inducing proinflammatory cytokine production from macro-
phages through Toll-like receptor 4 (TLR4) and c-Jun N-terminal
protein kinase (JNK) pathways (Norseen et al., 2012). Also, the
RBP4/retinol complex stimulates JAK2/STAT5 signaling and
expression of suppressor of cytokine signaling 3, which has
also been implicated in insulin resistance (Berry et al., 2011).
Several immunologic cell types regulate AT inflammation and
insulin sensitivity (Odegaard and Chawla, 2013). Macrophages
and dendritic cells (DC), which are both APCs (Steinman et al.,
2005), are present in healthy AT throughout the lifespan (Bertola
et al., 2012; Morris et al., 2013). Although leptin (Lord et al.,
1998), fatty acids (Nguyen et al., 2007), and other factors have
been implicated in APC activation, the molecular drivers of AT
inflammation are not well understood. AT macrophages (ATMF)
in healthy AT express anti-inflammatory markers typical of alter-
natively activated or M2 macrophages, which generally promote
tissue repair (Lumeng et al., 2007; Odegaard and Chawla, 2013).
Obesity triggers the accumulation of F4/80+ macrophages in AT
(Weisberg et al., 2003), which coexpress the DC marker
CD11c and proinflammatory genes typical of classically acti-
vated or M1 macrophages (Lumeng et al., 2007; Odegaard and
Chawla, 2013; Weisberg et al., 2003). Recently, AT APCs have
been implicated in insulin resistance (Bertola et al., 2012;
Cipolletta et al., 2012; Morris et al., 2013). In addition
to macrophages, lymphocytes in AT are also regulated by meta-
bolic status (Cipolletta et al., 2011; Goossens et al., 2012; Lynch
et al., 2012; Nishimura et al., 2009; Strissel et al., 2010; Winer
et al., 2011).
Depending on the signals during the interactions with APCs,
CD4 T cells can differentiate into pro- (T helper 1, Th1 and
Th17) or anti-inflammatory (Th2 and regulatory T cells, Treg) cells
(Zhu and Paul, 2008). Obesity is associated with a progressive
bias toward a proinflammatory Th1 phenotype in AT, which is
linked to insulin resistance (Winer et al., 2009). Moreover, insulin
sensitivity is improved in Th1 lineage-defining transcription
factor (T-bet)-deficient mice on high-fat diet (HFD) despite
increased visceral adiposity (Stolarczyk et al., 2013). The mech-
anisms that regulate the inflammatory fate of AT T cells are
unknown. CD4 T cells undergo polyclonal expansion within AT
in obesity (Feuerer et al., 2009; Ilan et al., 2010; Yang et al.,
2010). This implies that AT CD4 T cell expansion and polarization
are an adaptive immune response to obesity and insulin resis-
tance. Classically, APCs shape CD4 T cell activation by three
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pro- or anti-inflammatory CD4 T cell subsets: (1) presentation
of peptide antigens on major histocompatibility complex class
II (MHCII), (2) expression of T cell costimulatory molecules
(CD40, CD80, and CD86), and (3) production of cytokines.
Because RBP4 is elevated in many insulin-resistant states (Bala-
gopal et al., 2007; Graham et al., 2006; Meisinger et al., 2011; Qi
et al., 2007; Yang et al., 2005) and data indicate a causative role
(van Hoek et al., 2008), and because RBP4 induces inflammatory
responses in vitro (Norseen et al., 2012), we proposed that RBP4
triggers AT inflammation in vivo. We observed that elevated
RBP4 induces APC activation through the JNK pathway, which
results in proinflammatory CD4 T cell proliferation and Th1 polar-
ization. This is sufficient to promote systemic insulin resistance.
RESULTS
RBP4 Overexpression Results in AT Inflammation and
Systemic Insulin Resistance
Serum human RBP4 (hRNP4) levels in RBP4-Ox mice were 2- to
3-fold higher than endogenous mouse RBP4 (data not shown)
(Episkopou et al., 1993; Quadro et al., 2002; Yang et al., 2005)
and therefore closely represent the serumelevation ofRBP4 in in-
sulin-resistant ob/obmice, diet-induced obesemice (Mody et al.,
2008; Yang et al., 2005), and insulin-resistant human subjects
(Graham et al., 2006; Norseen et al., 2012; Yang et al., 2005)
compared to their normal counterparts. RBP4-Ox mice fed on
chow diet are glucose intolerant and insulin resistant (Figures
1A and 1B) with normal body weight, fat mass, serum triglycer-
ides, free fatty acids, and adiponectin (Figures 1C–1F). Previ-
ously, we showed that RBP4 has a proinflammatory effect
in vitro (Norseen et al., 2012). Because chronic inflammation is
a major factor contributing to insulin resistance, we investigated
the inflammatory status of the visceral AT of RBP4-Ox mice
compared to WT mice. Visceral AT of RBP4-Ox shows more
inflammation than WT AT (Figures 1G–1I). To characterize
visceral AT inflammation, we selected CD45+ cells from AT (see
Figure S1A available online) and analyzed the expression of sur-
facemarkers for specific subtypes of immune cells. First, AT cells
were divided in Ly6C+Ly6G cells (monocytes) and Ly6CLy6G+
cells (nonmonocyte myeloid cells) (Figure S1A). RBP4-Ox mice
have higher numbers of AT monocytes (Figure S1B) which
produce higher levels of proinflammatory cytokines including
TNF and IL-6 (Figure S1B). Next, we evaluated the population
of ATMF by selecting F4/80+CD11b+ cells that were negative
for the monocytic marker Ly6C. Back gate analysis of these
CD11b+F4/80+ AT cells revealed that the majority of ATMF
were Ly6G+ (Figure S1C). Hence, we considered ATMF to be
the cells with the phenotype of CD45+Ly6CLy6G+CD11b+F4/
80+. RBP4-Ox mice displayed more ATMF than WT littermates
(Figure 1G). Because the population of Ly6G+ cells (enriched
with ATMF) is also increased in RBP4-Ox, this results in a 70%
increase in ATMF compared with WT (Figure 1G). These ATMF
produced higher levels of TNF and IL-1b (Figure 1H), indicating
that RBP4 overexpression results in increased AT inflammation.
Since Ly6G is also a neutrophil marker, we evaluated the number
of neutrophils present in these AT samples. Because neutrophils
do not expressMHCII, we selected cells that are negative for this
marker. To exclude macrophages from this MHCII null popula-Cetion, we further selected for cells negative for the macrophage
markers, F4/80 and CD68, and subsequently, cells negative for
CD11c and CD206. After these gate exclusions, neutrophils
were identified by Gr-1 and CD11b expression (Figure S1D).
RBP4-Ox mice do not have increased numbers of neutrophils
compared to WT littermates (Figure S1E). To further understand
the inflammatory changes in RBP4-Ox mice, we evaluated
ATMF subpopulations. Proinflammatory macrophages have
increased CD11c and reduced CD206 expression and anti-
inflammatory macrophages have the opposite (Ferrante, 2013;
Lumeng et al., 2007; Nguyen et al., 2011) (Figure 1I, top panel).
RBP4-Ox mice displayed a 5-fold increase of CD11c+ and a
60% increase in CD206+macrophages (Figure 1I, bottom panel).
However, CD206+ macrophages were still more abundant in AT
of both genotypes. Together, our data indicate that RBP4-Ox
have increased numbers of macrophages of two distinct sub-
types, CD11c+ and CD206+.
RBP4 Overexpression Enhances Antigen Presentation
Capacity in Adipose Tissue Macrophages
Because RBP4-Ox ATMF produce more CD4 T cell-activating
cytokines (Figure 1H), we evaluated the population of these cells
in RBP4-Ox AT and found increased numbers of CD4 T cells
(Figure 2A).
Although obesity and insulin resistance are usually associated
with reduction in Treg cells (Cipolletta et al., 2011), lean RBP4-
Ox mice did not show any difference in AT Treg numbers and
percentages (Figure 2B). However, there were more memory
(CD4+CD44+) and activated (CD4+CD69+) T cells in AT of RBP4-
Ox mice (Figure 2C). RBP4-Ox had increased percentage and
number of CD4+ T cells producing IFN-g (Th1) (Figure 2D). No
differences in the population of Th2 (CD4+IL-4+) and Th17
(CD4+IL-17+) cells were observed (Figures S2A and S2B). Next,
we evaluated MHCII and costimulatory molecules (CD86 and
CD40) required for ATMF-mediated CD4 T cell activation and
found they were significantly increased in RBP4-Ox ATMF (Fig-
ure 2E). This elevationwas specific to CD206+ ATMF (Figure 2G),
as noelevation inMHCII, CD86, orCD40wasobserved inCD11c+
ATMF (Figure 2F). Thus, RBP4-Ox mice not only have a higher
number of CD11c+ and CD206+ ATMF, but also more of the
CD206+ATMFare likely to induceCD4Tcell activationcompared
with WT CD206+ ATMF. This is further demonstrated in Figure 4.
RBP4Overexpression Results inMild Liver Inflammation
but Not Systemic Inflammation
To determine whether increased ATMF and CD4 T cell numbers
in RBP4-Ox mice are localized (specific to perigonadal/visceral
AT) or systemic, we analyzed the spleen, mesenteric lymph
node (data not shown), subcutaneous AT, and liver of RBP4-Ox
mice compared to WT littermates. The increased number of AT
CD4+ T cells producing IFN-g (Th1) was specific to visceral AT,
as no increase in Th1 cells was observed in the spleen and lymph
node of RBP4-Oxmice compared toWT littermates (Figures S2C
and S2D). Moreover, no difference was observed in the numbers
or percentages of total CD4 T cells, Treg cells (data not shown),
monocytes, macrophages, or DCs (Figures S3A–S3E). Further-
more, no differences in the expression of MHCII or costi-
mulatory molecules were found in splenic DCs or macrophages
(Figures S3F and S3G). We next evaluated whether thell Metabolism 19, 512–526, March 4, 2014 ª2014 Elsevier Inc. 513
Figure 1. Elevated Serum RBP4 Levels Cause Glucose Intolerance, Insulin Resistance, and AT Inflammation
(A) Glucose tolerance test (left panel) and insulin tolerance test (right panel) (n = 13–15/group).
(B) Serum insulin levels (n = 13–15/group).
(C and D) (C) Body weight and (D) fat mass (n = 13–15/group).
(E) Serum triglyceride and free fatty acid (FFA) levels (n = 11–13/group).
(F) Serum adiponectin levels (n = 11–13/group).
(G) Flow cytometry representation of gated ATMF (CD11b+F4/80+). ATMF numbers in perigonadal fat (right panel) (n = 8/group).
(H) TNF and IL-1b intracellular staining in ATMF (n = 5/group).
(I) Flow cytometry representation (top panel) and number (botton panel) of CD11c+ and CD206+ ATMF (n = 8/group). Studies were performed at 12–16 weeks of
age. Values are means ± SEM. *p < 0.05. AUC, area under the curve. AAC, area above the curve. Pg, perigonadal.
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tion. No increase in the inflammatorymarkersCd11c,Tnf, and Il-6
or inArg-1wasobserved in subcutaneousAT (FigureS4A).More-
over, no change in the total number of CD11c+ or CD206+macro-
phages or CD4+ T cells was observed (Figures S4B–S4D). How-
ever, liver of RBP4-Ox mice displayed a modest increase in Tnf
expression compared to control littermates (Figure 3A). Flow cy-
tometryanalysis of these liver samplesshowedelevatednumbers
of total livermacrophages (Figure 3B) consisting of three different
phenotypes, CD11c+, CD206+, and CD11c+CD206+ (Figure 3C),514 Cell Metabolism 19, 512–526, March 4, 2014 ª2014 Elsevier Inc.and of macrophages expressing TNF, but not IL-1b (Figure 3D).
In contrast to ATMF (Figures 2E–2G), liver macrophages from
RBP4-Ox mice did not display increased levels of MHCII and
CD40 compared to WT macrophages (Figure 3E). In agreement
with these results, no difference in the total number of CD4
T cells or in the percentage or total number of Th1 cells was
observed (Figure 3F). To understand whether the differences in
liver and AT inflammation could be due to different RBP4 levels
in these tissues, we measured transgenic human RBP4 in
RBP4-Ox mice. Human RBP4 was 6-fold higher in perigonadal
Figure 2. Elevated Serum RBP4 Levels Activate the Adaptive Immune System in AT
(A) Total CD4+ AT T cell numbers.
(B) Flow cytometry representation of gated AT Tregs (left panel) fromWT and RBP4-Oxmice. CD4+CD25+Foxp3+ AT Treg percentages and numbers (right panel).
(C) Flow cytometry representation of gated CD4+Foxp3CD44+ (memory) and CD4+Foxp3CD69+ (activated) T cells (upper panel). Memory and activated CD4
T cell numbers (bottom panels).
(D) Flow cytometry representation of gated AT CD4 T cells stained intracellularly with IFN-g and IL-17 (left panel). Percentage and number of CD4+IFN-g+ T cells
(right panel).
(E) Total CD11b+F4/80+ ATMF fromWT and RBP4-Ox were evaluated for the expression of MHCII and costimulatory molecules (CD40, CD80, and CD86) by flow
cytometry (n = 5/group).
(F and G)MHCII and costimulatory molecule (CD40, CD80, and CD86) expression in gated CD11c+ (F) and CD206+ (G) ATMF (n = 5–6/group). Values aremeans ±
SEM. *p < 0.05. Pg, perigonadal.
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levels in serum, liver, and AT were not altered by hRBP4 overex-
pression (Figure 3H). These data indicate that increased RBP4
levels promote the accumulation of both CD11c+ and CD206+
macrophages in perigonadal AT and liver, but not in peripheral
lymphoid tissues or subcutaneous fat, and that RBP4-induced
CD4 T cell responses take place preferentially in perigonadalCeAT, possibly due to increased RBP4 levels in this adipose tissue
depot compared to liver.
RBP4 Overexpression Causes CD206+ Adipose Tissue
Macrophages to Express Proinflammatory Molecules
Since our data indicate that RBP4 overexpression promotes
CD11c+ and CD206+ ATMF accumulation (Figure 1I), well Metabolism 19, 512–526, March 4, 2014 ª2014 Elsevier Inc. 515
Figure 3. Elevated Serum RBP4 Levels Increase Liver Macrophages with No Effect on CD4 T Cell Activation
(A) Liver mRNA expression of Tnf, Il-6, Cd11c, and Arg-1 was determined by qPCR.
(B) Flow cytometry representation of liver macrophage (CD11b+F4/80+) gating and macrophage numbers in liver (right panel).
(C) Flow cytometry representation (left panel) and number (right panel) of CD11c+, CD11c+CD206+, and CD206+ liver macrophages.
(D) Flow cytometry representation of TNF and IL-1b intracellular staining in liver macrophages (left panel) and percentage and total number of TNF+macrophages
(right panel).
(E) MHCII and costimulatory molecule (CD40) expression in gated CD11c+, CD206+ or CD11c+CD206+ liver macrophages.
(F) Flow cytometry representation of gated AT CD4 T cells stained with IFN-g and IL-17 (upper panel). Percentage and number of CD4+IFN-g+ T cells (bottom
panel).
(G) Western blot of transgenic human RBP4 (hRBP4) in AT and liver (left panel) and quantification of blot (right panel).
(H) Levels of endogenous mouse RBP4 (mRBP4) in serum, AT, and liver of RBP4-Ox andWTmice using an antiserum that does not crossreact with human RBP4.
n = 4–6/group. Values are means ± SEM. *p < 0.05. Pg, perigonadal. MFI, median fluorescence intensity.
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RBP4 Is a Trigger of Adipose Tissue Inflammationperformed immunophenotyping of both ATMF subtypes. ATMF
were FACS sorted by surface markers into CD11c+ (Ly6C
CD11b+F4/80+CD11c+CD206)- or CD206+ (Ly6CCD11b+F4/
80+CD11cCD206+)-positive populations. The expression of
other markers enriched in classically activated and alternatively
activatedmacrophages (Ferrante, 2013; Han et al., 2013; Nguyen
etal., 2011)wereevaluated toverifyATMFpolarization (Figure4A).
RBP4overexpression increased the expression of classically acti-
vated macrophage related markers in CD206+ ATMF to levels
similar (Tnf) and even higher (Il-1b and Il-12) than in CD11c+
ATMF (Figure 4A) without decreasing the expression of alterna-
tively activated macrophage-related markers (Figure 4B). These
data confirm thatRBP4overexpressionupregulatesproinflamma-
torycytokines inATMF thatexpressalternativelyactivatedmacro-
phage markers.
Adipose Tissue CD206+ Macrophages of RBP4-Ox Are
Potent Inducers of Th1 T Cells
ATMF are sufficient to induce CD4 T cell proliferation (Morris
et al., 2013). Thus, we next measured the capacity of purified
AT CD11b+ cells (enriched with ATMF) to trigger CD4 T cell
proliferation. CD11b+ cells from RBP4-Ox mice induced greater
proliferation of CD4 T cells than WT CD11b+ cells (Figure S5A).
To determine whether both CD11c+ and CD206+ ATMF induce
CD4 T cell proliferation, we FACS sorted ATMF and cocultured
them with syngeneic WT splenic CD4 T cells. CD11c+ and
CD206+ macrophages from both WT and RBP4-Ox mice
induced greater proliferation of CD4 T cells compared with total
myeloid (CD11b+) cells (Figure S5B). CD11c+ and CD206+ ATMF
from RBP4-Ox mice induced greater proliferation of CD4 T cells
compared to WT ATMF (Figures 4C and 4D). Importantly,
CD206+ ATMF from RBP4-Ox mice induced greater CD4 T cell
proliferation than CD11c+ ATMF from WT and RBP4-Ox mice
and CD206+ ATMF from WT mice (Figures 4C and 4D).
To determine whether these ATMF also affect CD4 T cell po-
larization, the intracellular cytokine content of cocultured CD4
T cells was measured. Although neither CD11c+ nor CD206+
ATMF from RBP4-Ox and WT mice was able to induce Th17
polarization (Figure S5C), they induced Th1 T cell polarization
(Figures 4E and 4F). No difference in the induction of Th1 cells
was observed between CD4 T cells cocultured with CD11c+
ATMF from WT compared to RBP4-Ox mice. In contrast,
CD206+ ATMF from RBP4-Ox mice induced higher percentage
of Th1 cells compared to WT CD206+ ATMF (Figures 4E and
4F) and higher proliferation of Th1 cells (Figure S5D). IFN-g pro-
duction, which is characteristic of Th1 cells, by CD4 T cells was
higher when they were cocultured with CD206+ ATMF fromFigure 4. RBP4 Overexpression Increases Proinflammatory Markers in
(A and B) mRNA expression of classically activated (A) and alternatively activate
CD206+ Pg ATMF from RBP4-Ox and WT mice (n = 3 experiments pooling AT fr
(C) Flow cytometry representation of CD4 T cell proliferation induced by cocultu
dilution.
(D) Expansion index representing the degree of CD4 T cell proliferation.
(E) Flow cytometry representation of IL-4 and IFN-g intracellular staining in CD4+
(F) Percentage of IFN-g+CD4+ T cells in the coculture assay.
(G) IFN-g levels in media from coculture of CD11c+ or CD206+ ATMF with CD4 T
(H) mRNA expression in the coculture assay of CD4 T cell lineage transcription fac
ATMF pooled from six to tenWT or RBP4-Ox mice and incubated with syngeneic
or as indicated. #p < 0.05 versus control. Pg, perigonadal.
518 Cell Metabolism 19, 512–526, March 4, 2014 ª2014 Elsevier Inc.RBP4-Ox mice compared with CD206+ ATMF from WT mice
(Figure 4G). No polarization to Th2 or Th17 was observed in
the coculture assay as indicated by lack of IL-4 or IL-17 secretion
(data not shown). To further confirm Th1 polarization, we
measured CD4 T cell lineage transcription factor (Tbx21) expres-
sion in cocultured cells. Tbx21 was upregulated in the coculture
of CD206+ ATMF from RBP4-Ox with CD4 T cells compared to
CD206+ ATMF from WT mice and compared to CD11c+ ATMF
from both genotypes (Figure 4H). This was reinforced by
increased AT Tbx21 expression in RBP4-Ox compared to WT
mice (Figure S5E). Th2 (Gata-3), Th17 (Rorc), and Treg (Foxp3)
transcription factor expression was unchanged. These results
indicate that CD206+ ATMF from RBP4-Ox mice retain their
alternatively activated macrophage phenotype but potently
activate and promote a proinflammatory Th1 profile.
RBP4 Directly Activates Antigen-Presenting Cells
We wanted to determine whether treatment of APCs with RBP4
is sufficient to cause insulin resistance in vivo. Because (1) both
macrophages and DCs are professional APCs, (2) the yield of
bone marrow-derived dendritic cells (BMDCs) is much greater
than bone marrow-derived macrophages (BMDMs), and (3) DC
transfer systems are far better worked out than macrophage
transfer systems (Quintana et al., 2010; Ruffner and Robbins,
2010; Sivaganesh et al., 2013), we activated BMDC with RBP4
for in vivo transfer experiments. RBP4 potently activated
BMDC in a dose-dependent manner, as evidenced by upregula-
tion of MHCII, costimulatory molecules (Figures 5A and S5F),
and of proinflammatory cytokines (Figure 5B). The induction of
IL-12 was confirmed by intracellular staining in CD11c+MHCII+
BMDC (Figure 5C). Moreover, RBP4-activated BMDC induced
CD4 T cell proliferation (Figures 5D and 5E). RBP4-activated
BMDCs cocultured with CD4 T cells resulted in increased IFN-
g secretion (Figure 5F) and IFN-g and TNF intracellular staining
in CD4 T cells (Figure 5G), indicative of Th1 T cell polarization.
There was no induction of other CD4 T cell subtypes indicated
by reduced IL-4 and IL-17 intracellular staining (Figure 5G).
These results were confirmed by increased expression of
Tbx21 and not of Gata-3, Rorc, and Foxp3 (Figure 5H). Thus,
RBP4 directly activates BMDCs and causes Th1 polarization.
The RBP4 effects on CD4 T cells are mediated by activation of
APCs, as RBP4 has no direct effect on splenic CD4 T cells
in either WT or RBP4-Ox mice (Figure S5G). Proteomic and lipi-
domic mass spectrometry analysis of our RBP4 preparation
confirmed its purity and showed no contaminating endotoxin
(LPS), other lipopolysaccharides, lipoproteins, lipids, or addi-
tional proteins (Figures S6A and S6B; Norseen et al., 2012).CD206+, Alternatively Activated ATMF, Resulting in Th1 Polarization
d (B) macrophage-related markers in FACS-sorted (98% purity) CD11c+ and
om 10–12 mice/group in each experiment).
re with CD11c+ and CD206+ ATMF. Proliferation was evaluated by cell-trace
T cells cocultured with CD11c+ or CD206+ ATMF.
cells.
tors. Coculture assays were performed with FACS-sorted CD11c+ and CD206+
splenic CD4 T cells. Values are means ± SEM. *p < 0.05 versus all other groups
Figure 5. RBP4 Directly Activates Dendritic Cell, which Induce CD4 T Cell Proliferation and Polarization
DCs were generated from bone marrow (BMDCs) of 8-week-old male WT mice.
(A) DC activation was demonstrated by increased expression of CD40, CD80, CD86, and MHCII determined by flow cytometry.
(legend continued on next page)
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RBP4 Is a Trigger of Adipose Tissue InflammationAbsence of potential lipopolysaccharide contamination is further
demonstrated by the fact that boiling, which would denature the
RBP4 protein, removed the effect of RBP4 to stimulate TNF
secretion from BMDC, but not the effect of LPS (Figure S6C). If
LPS was present, the proinflammatory effect of RBP4 would
persist after boiling. In addition, recombinant RBP4 generated
from mammalian cells (Figure S6D) and hRBP4 purified from
human blood (data now shown), where the potential exposure
to LPS is minimal, had the same inflammatory effect as bacteri-
ally derived RBP4. A summary of the data confirming the purity of
our RBP4 preparation is shown in Table S1.
Transfer of RBP4-Activated APCs intoWTMice Leads to
Adipose Tissue Inflammation and Insulin Resistance
To determine whether RBP4 activation of APCs is sufficient
to cause AT inflammation and insulin resistance, we performed
APC transfer experiments. Control (not activated) immature
dendritic cells (iDCs) and RBP4-activated mature dendritic cells
(mDCs) were transferred into leanWTmice. Transfer of mDC but
not iDC or PBS alone resulted in insulin resistance (Figures 6A
and 6B). Transfer of RBP4-activated BMDC (mDC) also resulted
in elevated fasting glucose levels (Figure 6C), glucose intoler-
ance (Figures 6D and 6E), and increased insulin levels (Figure 6F)
with no change in body weight or adiponectin levels (Figure 6G).
Moreover, mDC transfer resulted in increased ATMF and ATMF-
producing proinflammatory cytokines (Figure 6H). A switch from
a predominant CD206+ phenotype to a CD11c+ phenotype
occurred when mice received mDCs (Figure 6I). Because
RBP4 activates APCs and increases their capacity to activate
CD4 T cells, we analyzed the AT CD4 T cell profile. Transfer of
mDC resulted in increased numbers of total CD4 T cells and
CD4 T cells producing IFN-g and TNF (Figures 6J and 6K).
Thus, BMDC activation by RBP4 is sufficient to cause AT inflam-
mation and insulin resistance in normal mice.
RBP4-Induced Activation of Macrophages and Antigen
Presentation to CD4 T Cells Are Partially Dependent on
JNK Signaling
Previously we showed that the JNK pathway is important for
RBP4-induced macrophage activation in vitro (Norseen et al.,
2012). JNK1 and JNK2 in macrophages are required for induc-
tion of AT inflammation and insulin resistance in obesity (Han
et al., 2013). Therefore, we analyzed the activation status of
JNK in CD45+CD11b+ AT cells (myeloid cells enriched in macro-
phages) in both RBP4-Ox and WT mice. RBP4-Ox mice display
increased phosphorylation of JNK in CD45+CD11b+ cells
compared to WT mice (Figure 7A). In addition, RBP4 effects on
macrophages and DCs are STRA6 independent, since these(B) Dose-response effect of RBP4 on secretion of TNF, IL-6, and IL-12 from BMD
(C) Increased production of IL-12 by RBP4- or LPS-activated BMDC was confirm
(D) RBP4- or LPS-activated BMDCswere coculturedwith splenic syngeneic cell-tr
trace dilution.
(E) Expansion index representing the degree of CD4 T cell proliferation.
(F) IFN-g secretion on day 5 of coculture.
(G) RBP4-activated BMDCs induce IFN-g and TNF production by CD4 T cells, v
(H) mRNA expression in the coculture assay of CD4 T cell lineage transcription fact
of bone marrow cells from two to six mice. Values are means ± SEM. *p < 0.05 ve
dialysate control.
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induced cytokine/chemokine (TNF, IL-6, IL-12, IL-1b, IFN-g,
and MCP1), MHCII, and costimulatory molecule levels were
significantly reduced in both JNK 1/2 KO BMDM compared to
WT BMDM and in WT BMDM in the presence of JNK inhibitor
(Figures S7B and S7C).
To assess JNK involvement in AT CD11c+ and CD206+macro-
phages, we FACS sorted CD11c+ and CD206+ macrophages
from WT mice and stimulated them in vitro with RBP4 in the
presence or absence of JNK inhibitor. RBP4 equally upregulated
TNF, IL-6, IL-12, and IL-1b in both CD11c+ and CD206+ macro-
phages (Figure 7B), indicating activation of both populations of
cells. Treatment with JNK inhibitor reduced the RBP4-induced
upregulation of cytokines in both CD11c+ and CD206+ macro-
phages (Figure 7B), indicating that RBP4 activation of both
populations of macrophages is partially JNK dependent. Next,
we sorted CD11c+ and CD206+ macrophages from JNK1/2
KO and control WT mice and treated them in vitro with RBP4.
RBP4 induced the secretion of TNF, IL-12, and IL-1b in both
CD11c+ and CD206+ ATMF from WT mice to similar levels (Fig-
ure 7C). RBP4-induced IL-6 secretion was lower in CD206+ than
in CD11c+ AT macrophages from WT mice. JNK1/2 KO CD11c+
and CD206+ ATMF displayed decreased secretion of these
cytokines (Figure 7C), with a complete block in RBP4-induced
IL-6 and IL-1b secretion.
Because JNK ablation inhibited RBP4-induced activation of
AT macrophages, we next investigated the outcome of this inhi-
bition on CD4 T cell proliferation and Th1 polarization. RBP4-
activated CD11c+ and CD206+ ATMF induce CD4 proliferation
and Th1 polarization (Figures 7D and 7E). RBP4-activated
CD11c+ and CD206+ ATMF from JNK1/2 KO mice displayed
reduced capacity to induce CD4 T cell proliferation (Figures 7D
and 7E) and Th1 polarization compared to WT (Figures 7D and
7E). Thus, RBP4 activation of both CD11c+ and CD206+ ATMF
and induction of CD4 T cell activation by both CD11c+ and
CD206+ ATMF depend on JNK signaling.
DISCUSSION
The mechanisms for RBP4-induced insulin resistance in vivo are
unknown. Here we show that RBP4 directly activates AT APCs
in a JNK-dependent manner, induces CD206+ macrophages
to secrete proinflammatory cytokines, and triggers CD4 T cell
polarization (Th1) and proliferation. Elevation of RBP4 results in
greater inflammation in AT than in liver. In both tissues, the innate
immune system (macrophages) is activated, but the adaptive im-
mune system (CD4 T cells), which amplifies the inflammation, is
activated only in visceral AT. APC activation by RBP4 is sufficientCs.
ed by intracellular staining of CD11c+MHCII+ (BMDCs).
ace-labeled CD4 T cells, and CD4 T cell proliferation was demonstrated by cell-
isualized by intracellular staining using flow cytometry.
ors. Data represent three experiments performed in triplicate, each using pools
rsus dialysate. #p < 0.05 versus LPS. MFI, median fluorescence intensity. Dia,
(legend on next page)
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RBP4 Is a Trigger of Adipose Tissue Inflammationto cause insulin resistance, since transfer of RBP4-activated
APCs into normal mice induces AT inflammation and impairs
glucose tolerance and insulin sensitivity.
In obesity and other insulin-resistant states, AT macrophage
polarization spans a spectrum, and the optimal constellation of
markers to define pro- and anti-inflammatory macrophages is
still evolving. Proinflammatory ATMF which express CD11c+
(used as a marker for classically activated, also called M1,
macrophages) are generally increased leading to inflammation-
induced insulin resistance (Lumeng et al., 2007). This results in
a reduction in the relative number of CD206+ macrophages
(alternatively activated or M2 macrophages) which are predom-
inantly anti-inflammatory (Fujisaka et al., 2009; Han et al., 2013;
Lumeng et al., 2007; Stein et al., 1992). In AT of RBP4-Ox mice,
not only CD11c+ macrophages but also CD206+ macrophages
are increased. In addition, in RBP4-Ox AT, CD206+ macro-
phages unexpectedly produce proinflammatory cytokines and
express elevated amounts of costimulatory molecules required
for CD4 T cell activation, which are typical of CD11c+ macro-
phages (Lumeng et al., 2007; Stein et al., 1992). Importantly,
although these CD206+macrophages have increased proinflam-
matory cytokine expression, they retain the expression of mole-
cules that are usually associated with alternatively activated
macrophages (Lumeng et al., 2007; Odegaard and Chawla,
2011). Because CD206+ macrophages are 20 times more abun-
dant than CD11c+ macrophages in AT of RBP4-Ox mice, the
changes in CD206+ macrophages may play a significant role in
AT inflammation.
Accumulation of ATMF is only part of the immune response
that causes insulin resistance. T cells are also recruited to AT
during the development of obesity-related insulin resistance
(Feuerer et al., 2009; Nishimura et al., 2009; Winer et al., 2009).
We show in RBP4-Ox mice and with RBP4 treatment of immune
cells in vitro that RBP4-activated CD11c+ and CD206+ ATMF
induce CD4 T cell proliferation and Th1 polarization. Thus,
RBP4 increases the capacity of ATMF to induce a CD4 T cell
immune response. Moreover, transfer of RBP4-activated APCs
into normal mice is sufficient to increase CD4 T cell numbers,
Th1 polarization, and systemic insulin resistance. Th1 cells
play a critical role in AT inflammation, as the knockdown of these
cells (Tbet/) or their product (IFN-g) reduces AT inflammation
and insulin resistance during obesity (Stolarczyk et al., 2013;
Strissel et al., 2010; Winer et al., 2009; Yang et al., 2010).Figure 6. Transfer of RBP4-Activated APCs into WT Recipient Mice Ca
DCs were generated from the bone marrow (BMDCs) of WT mice. BMDCs were
without cells (control), iDCs or mDCs were injected i.p. in WT mice once a week
(A) Insulin tolerance test (ITT).
(B) Area above the curve of the ITT.
(C) Glycemia 5 hr following food removal.
(D) Glucose tolerance test.
(E) Area under the curve of the GTT.
(F) Serum insulin levels 5 hr following food removal.
(G) Body weight and serum adiponectin levels.
(H) Flow cytometry representation of gated ATMF (upper panel) and total numbe
(I) Flow cytometry representation of gated CD11c+ and CD206+ ATMF (left panel).
CD206+ ATMF (bottom right).
(J) Flow cytometry representation of gated CD4+, CD4+IFN-g+, and CD4+TNF+ A
(K) Total AT CD4 T cell numbers (left panel). CD4+IFN-g+ and CD4+TNF+ AT T ce
Values are means ± SEM. *p < 0.05 versus all other groups. #p < 0.05, mDC vers
522 Cell Metabolism 19, 512–526, March 4, 2014 ª2014 Elsevier Inc.Although a reduction in anti-inflammatory Treg cells has been
implicated in obesity-related insulin resistance (Feuerer et al.,
2009), lean insulin-resistant RBP4-Ox mice do not display
reduced Treg numbers, indicating that the role of Treg cells
may differ in lean versus obese insulin-resistant states.
JNK expression in macrophages is required for both AT
inflammation and obesity-induced insulin resistance (Han
et al., 2013). We previously demonstrated that activation of mac-
rophages in vitro by RBP4 was dependent on the JNK pathway
(Norseen et al., 2012). Here we show that JNK signaling is
required in vivo for RBP4-mediated proinflammatory cytokine
secretion and for expression of MHCII and costimulatory mole-
cules by ATMF. Moreover, we show that JNK signaling in
RBP4-treated APCs is required for activation of CD4 T cells. In
agreement with our results, the JNK pathway has been impli-
cated not only in the accumulation and activation of AT macro-
phages (Han et al., 2013) but also in Th1 immune responses in
obesity (Davis, 2000; Dong et al., 1998, 2000; Wang et al., 1994).
RBP4 undoubtedly is not the only AT-derived factor that is
important for AT inflammation and T2D. For example, leptin
and free fatty acids also induce proinflammatory cytokine pro-
duction (Lord et al., 1998; Nguyen et al., 2007). However, our
data identify RBP4 as a key endogenous protein that contributes
to AT inflammation and insulin resistance by triggering an inter-
play of the innate and adaptive immune systems (Figure 7F).
These findings conceptually advance our understanding of the
integration of different inflammatory pathways in AT in insulin-
resistant states and may have therapeutic implications for type
2 diabetes.
EXPERIMENTAL PROCEDURES
Animal Studies and Measurement of Metabolic Parameters
Male RBP4-overexpressing (RBP4-Ox) mice on a C57BL6 background were
bred with female C57BL6/J mice (Jackson Laboratories) to generate RBP4-
Ox mice and control littermates. The RBP4-Ox mice express human-RBP4
under the control of mouse muscle creatine kinase (MCK) promoter and
were extensively characterized (Quadro et al., 2002). Male mice 14–19 weeks
of age were used for all studies. Male macrophage-specific JNK1/2 knockout
mice (8 weeks old) were provided by Dr. Roger J. Davis and were previously
described (Han et al., 2013). Body composition was measured by NMR
(Echo Medical Systems). Insulin (ITT) and glucose (GTT) tolerance tests were
performed in awake mice after a 5 hr fast and a 12 hr fast, respectively. Blood
glucose was determined using a One Touch Basic glucometer (Lifescan).
Mouse studies were conducted in accordance with federal guidelines. Theuses Insulin Resistance, Glucose Intolerance, and AT Inflammation
treated with dialysate (not activated; iDC) or activated with RBP4 (mDC). PBS
for 6 weeks.
r of ATMF and ATMF expressing TNF or IL-1b (bottom panel).
Percent of CD11c+ and CD206+ ATMF (top right). Total number of CD11c+ and
T T cells.
ll numbers and percentages (right panel) (n = 8–10/group for all experiments).
us iDC. Pg, perigonadal.
Figure 7. RBP4-Induced Activation of Adipose Tissue Macrophages and Resulting CD4 T Cell Proliferation and Th1 Polarization Are JNK
Dependent
(A) Histograms representing pJNK staining (pT183/pY185) (upper panel) and normalized pJNK levels (bottom panel) in CD45+CD11b+ AT cells fromRBP4-Ox and
WT mice.
(B) CD11c+ and CD206+ ATMwere sorted fromWTmice and stimulated with RBP4 (50 mg/mL for 24 hr) in the presence or absence of JNK inhibitor (5 mM). Levels
of TNF, IL-6, IL-12, and IL-1b were measured by ELISA.
(C) CD11c+ andCD206+ ATMwere sorted frommacrophage-specific JNK1/2 knockout (JNK KO) andWTmice and treated with RBP4 (50 mg/mL for 24 hr). Levels
of TNF, IL-6, IL-12, and IL-1b were measured by ELISA.
(D) CD11c+ and CD206+ ATM were sorted from JNK KO and WT mice and treated with RBP4 (50 mg/mL for 24 hr). Next, WT CD4 T cells plus anti-CD3 antibody
were added, and CD4 T cell proliferation and IFN-g+CD4+ T cells were measured. Flow cytometry representation of CD4 T cell proliferation (left panel) and IFN-g
and IL-17 intracellular staining in gated CD4 T cells (right panel).
(E) Expansion index representing the degree of CD4 T cell proliferation (left panel) and IFN-g+ secretion in the coculture assay (right panel) (n = 4/group). Values are
means ± SEM. *p < 0.05 versus dialysate control. #p < 0.05, versus WT macrophages treated with RBP4 and no JNK inhibitor (B) or versus WT macrophages
treated with RBP4 (C and E). Pg, perigonadal.
(legend continued on next page)
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Center [BIDMC], Boston) approved all studies. All studies were performed on
age- and sex-matched littermates.
Recombinant RBP4 Preparation
Human RBP4was expressed in Escherichia coli and purified as described pre-
viously (Yang et al., 2005). Endotoxin was removed by sequential affinity
adsorption to Endotrap matrix (Hyglos GmbH) and Detoxigel (Pierce). Recom-
binant RBP4 protein purity was determined by Coomassie staining of SDS-
PAGE gels and mass spectrometry with and without a strong cation exchange
cleanup.
Generation and RBP4 Treatment of Bone Marrow-Derived Dendritic
Cells and Macrophages
Mouse bone marrow cells were obtained as previously described (Moraes-
Vieira et al., 2013b). GM-CSF (R & D Systems) at a concentration of 20 ng/
mL was used for BMDC differentiation. M-CSF at a concentration of 50 ng/
mLwas used for BMDMdifferentiation. RBP4was used at a final concentration
of 1, 25, or 50 mg/mL. The dialysate buffer was used as a vehicle control in ex-
periments where indicated. For analysis of cytokine secretion in BMDMs and
ATMF, these cells were pretreated with 5 mMJNK inhibitor (EMD catalog num-
ber 420119) for 30 min and then incubated with RBP4 for 24 hr.
Bead Purification, Cell Sorting, and Coculture Assay
CD4+ T cells from the spleen of donor C57B6/J male age-matched mice and
CD11b+ cells from the perigonadal AT of RBP4-Ox or WT mice were purified
by magnetic beads as described by the manufacturer (Miltenyi). Liver
immune cells and AT stromal vascular fractions (SVFs) were isolated as previ-
ously described (Nguyen et al., 2007; Pien and Biron, 2000). AT SVFs were
stained with fluorescence-labeled antibodies for CD45, CD11b, Ly6C, F4/80,
CD11c, and CD206 (Biolegend) and sorted at high speed (BD FACSAria II,
Beth Israel Deaconess Medical Center Flow Cytometry Core). After sorting,
cells purities were higher than 98%.
Flow Cytometry of Surface Markers, Intracellular Cytokine, and
Foxp3 Transcription Factor
The AT SVF cells or BMDCs were resuspended in PBS supplemented with 2%
FCS, and surface markers were stained with monoclonal antibody for multi-
color flow cytometry. For intracellular cytokine staining, cells were stained
as previously described (Moraes-Vieira et al., 2013a). To determine the fre-
quency of Tregs (CD4+CD25+Foxp3+) in vivo, cells were stained intracellular
for Foxp3 using a PE anti-mouse/rat Foxp3 antibody kit (eBioscience). The
cells were acquired on a specially ordered five-laser LSR II flow cytometer
(BD Biosciences) at the Beth Israel DeaconessMedical Center Flow cytometry
core and analyzed with FlowJo 9.5.3 software (Treestar).
CD4+ T Cell Proliferation Assay
FACS-sorted CD11c+ (Ly6CCD11b+F4/80+CD11c+CD206) or CD206+
(Ly6CCD11b+F4/80+CD11c+CD206) or bead-purified AT CD11b+ cells
or BMDC from WT C57B6/J (not activated, dialysate or activated with
RBP4 or LPS) were cocultured with cell-trace violet-labeled bead-
purified splenic syngeneic CD4+ T cells from WT mice. Anti-CD3 antibody
(Biolegend) was added. The expansion index was calculated with FlowJo
9.5.3 software.
Gene Expression Analysis
RNA from CD11c+ and CD206+ ATMF sorted from the AT pooled from 10–12
WT or RBP4-Ox mice was extracted using a RNeasy Mini Kit (QIAGEN)
according to the manufacturer’s instructions. Each sample was run in
duplicate and relative expression levels determined using the 2DCt method
with normalization of target gene expression levels to Gapdh (Applied
Biosystems).(F) Elevation of RBP4 in serum activates resident ATMF and DCs and induces pr
molecules in AT through a JNK-dependent pathway. The proinflammatory molecu
These AT APCs induce CD4 T cell proliferation and Th1 polarization, resulting in inc
inflammation and systemic insulin resistance.
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DCs were treated with RBP4 (50 mg/mL) or vehicle (dialysate). The cells were
purified with CD11c+ beads (Miltenyi). BMDC (nonactivated—dialysate, iDC)
and RBP4-activated BMDC (mDC) were injected i.p. into WT mice (3 3 106
per mouse) once a week for 6 weeks. PBS was injected as control. Three
days after the last transfer of BMDC, fasting glucose levels were obtained,
and 5 days after the last transfer, ITT or GTT was performed. The mice were
sacrificed 1 week after the last cell transfer and the perigonadal AT SVF was
analyzed.
Analytical Procedures
Triglyceride levels were measured by colorimetric enzyme assays, and free
fatty acid levels were measured in serum using the NEFA-C kit (Wako, Rich-
mond). Cytokines (Biolegend), adiponectin (Invitrogen) and insulin (Crystal
Chem Inc.) were measured by ELISA kits. RBP4 tissue and serum levels
were measured by western blot as described (Yang et al., 2005).
Statistics
All values are given as means ± SEM. Differences among groups were
compared using ANOVA with Tukey post-test for multiple comparisons and
Student’s t test when there were only two groups. All statistical analyses
were performed using GraphPad PRISM 5 software, and the differences
were considered significant when p < 0.05.
SUPPLEMENTAL INFORMATION
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